LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 42.67 | 771.67 | 1838 | 5155 | 0.3565 | 0.3726 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 42.67 | 771.67 | 2228 | 5155 | 0.4321 | 0.4725 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 44.89 | 771.67 | 1932 | 5541 | 0.3486 | 0.3808 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 44.89 | 771.67 | 2405 | 5541 | 0.4340 | 0.4913 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 47.11 | 771.67 | 2061 | 5941 | 0.3469 | 0.3960 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 47.11 | 771.67 | 2527 | 5941 | 0.4253 | 0.4961 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 49.33 | 771.67 | 2150 | 6392 | 0.3363 | 0.3992 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 49.33 | 771.67 | 2683 | 6392 | 0.4197 | 0.5046 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 51.55 | 771.67 | 2278 | 6829 | 0.3335 | 0.4107 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 51.55 | 771.67 | 2808 | 6829 | 0.4111 | 0.5077 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 53.77 | 771.67 | 2410 | 7256 | 0.3321 | 0.4222 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 53.77 | 771.67 | 2983 | 7256 | 0.4111 | 0.5192 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 55.99 | 771.67 | 2512 | 7690 | 0.3267 | 0.4274 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 55.99 | 771.67 | 3188 | 7690 | 0.4146 | 0.5337 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 58.21 | 771.67 | 2680 | 8085 | 0.3315 | 0.4439 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 58.21 | 771.67 | 3215 | 8085 | 0.3976 | 0.5236 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 60.44 | 771.67 | 2851 | 8530 | 0.3342 | 0.4579 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 60.44 | 771.67 | 3368 | 8530 | 0.3948 | 0.5297 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 62.66 | 771.67 | 2969 | 8978 | 0.3307 | 0.4631 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 62.66 | 771.67 | 3565 | 8978 | 0.3971 | 0.5407 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 64.88 | 771.67 | 3055 | 9447 | 0.3234 | 0.4634 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 64.88 | 771.67 | 3722 | 9447 | 0.3940 | 0.5456 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.10 | 771.67 | 3195 | 9800 | 0.3260 | 0.4733 | MN20160304_L01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.10 | 771.67 | 3859 | 9800 | 0.3938 | 0.5511 | MN20160304_L01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 69.32 | 771.67 | 3335 | 10212 | 0.3266 | 0.4811 | MN20160304_L01 | H06 |